RET and medullary thyroid gland carcinoma: Soon after the discovery of the driving role of RET mutations in the pathogenesis of MTC [4,8] RET genetic screening in patients with hereditary and sporadic MTC has been introduced in the clinical practice to identify RET positive subjects and their relatives who are at high risk of developing MTC during their life.